Covaxin Gets DCGI nod for Emergency Use for Children Aged 12-18
New Delhi: Amid growing concern over the new Covid variant Omicron, Hyderabad-based vaccine manufacturer Bharat Biotech's Covaxin on Saturday got approval from the Drug Controller General of India (DGCI) for emergency use for children aged…